NGAL AS A MARKER FOR THE EFFICIENCY OF PERCUTANEOUS CORONARY INTERVENTION

Download full text PDF
Issue: 
10
Year: 
2015

M. Zykov (1), Candidate of Medical Sciences; V. Kashtalap (1,2), Candidate of Medical Sciences; I. Bykova (1); V. Kalaeva (1); O. Khryachkova (1); Professor V. Karetnikova (1,2), MD; Professor O. Barbarash (1,2), MD 1 -Research Institute for Complex Problems of Cardiovascular Diseases, Kemerovo 2 -Kemerovo State Medical Academy

The authors studied the prognostic value of the concurrent use of the GRACE scale and serum neutrophil gelatinase-associated lipocalin (NGAL) estimated during hospital stay in ST-elevation myocardial infarction patients who had undergone percutaneous coronary intervention.

Keywords: 
myocardial infarction
serum NGAL
prognosis



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. The 10 leading causes of death in the world, 2000 and 2011, Fact sheet № 310 of WHO. Rezhim dostupa: http://www.who.int/mediacentre/ factsheets/fs310/en/index.html
  2. Samorodskaja I.V. Ostrye formy ishemicheskoj bolezni serdtsa: neob hodimost' reshenija problemy sopostavimosti dannyh o rasprostranennosti i letal'nosti // Bolezni serdtsa i sosudov. – 2010; 1: 25–8.
  3. Alekjan B.G., Abrosimov A.V. Sovremennoe sostojanie rentgenendovasku- ljarnogo lechenija ostrogo koronarnogo sindroma i perspektivy ego razvitija v Rossijskoj Federatsii // Kompleksnye problemy serdechno-sosudistyh zabolevanij. – 2013; 1: 5–9.
  4. Baber U., Stone G., Weisz G. et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes // JACC Cardiovasc. Imaging. – 2012; 5: 53–61.
  5. Bawamia B., Mehran R., Qiu W. et al. Risk scores in acute coronary syndrome and percutaneous coronary intervention: a review // Am. Heart J. – 2013; 165 (4): 441–50.
  6. Shafranskaja K.S., Kashtalap V.V., Bazdyrev E.D. i dr. Vozmozhnosti diagnostiki ostrogo povrezhdenija pochek s ispol'zovaniem lipokalina, asso-tsiirovannogo s zhelatinazoj nejtrofilov (NGAL) v kardiologii (obzor literatury) // Sib. med. zhurn. – 2011; 26 (4, vyp. 1): 15–9.
  7. Shen S., Hu Z., Li Q. Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease // Nephrology (Carlton). – 2014; 19 (3): 29–35.
  8. Zografos T., Haliassos A., Korovesis S. et al. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease // Am. J. Cardiol. – 2009; 104: 917–20.
  9. Palmerini T., Genereux P., Caixeta A. et al. A New Score for Risk Stratification of Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy–Percutaneous Coronary Intervention) Risk Score // JACC. – 2012; 5: 1108–16.
  10. Saltzman A., Stone G., Claessen B. et al. Long-Term Impact of Chronic Kidney Disease in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention // JACC. – 2011; 4: 1011–9.
  11. Keeley E., Boura J., Grines C. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials // Lancet. – 2003; 361 (9351): 13–20.
  12. Hemdahl A., Gabrielsen A., Zhu C. et al. Expression of neutrophil gelatinase associated lipocalin in atherosclerosis and myocardial infarction // Arterioscler. Thromb. Vasc. Biol. – 2006; 26 (1): 136–42.
  13. Zografos T., Haliassos A., Korovesis S. et al. Association of neutrophil gelatinase-associated lipocalin with the severity of coronary artery disease // Am. J. Cardiol. – 2009; 104: 917–20.
  14. Choi K., Lee J., Kim E. et al. Implication of lipocalin-2 and visfatin levels . in patients with coronary heart disease // Eur. J. Endocrinol. – 2008; 158: 203–7
  15. Haase M., Bellomo R., Devarjan P. et al. Novel biomarkers early predict the severity of acute kidney injury after cardiac surgery in adults // Ann. Thorac. Surg. – 2009; 88: 124–30.
  16. Mishra J., Ma Q., Prada A. et al. Identification of neutrophil gelatinaseassociated lipocalin as a novel early biomarker for ischemic renal injury // J. Am. Soc. Nephrol. – 2003; 14: 2534–43.
  17. Alvelos M., Louren17. ço R., Dias C. et al. Prognostic value of neutrophil gelatinase-associated lipocalin in acute heart failure // Int. J. Cardiol. – 2013; 165: 51–5.
  18. Shrestha K., Shao Z., Singh D. et al. Relation of systemic and urinary neutrophil gelatinase-associated lipocalin levels to different aspects of impaired renal function in patients with acute decompensated heart failure // Am. J. Cardiol. – 2012; 110: 1329–35.
  19. Torregrosa I., Montoliu S., Urios A. et al. Early biomarkers of acute kidney failure after heart angiography or heart surgery in patients with acute coronary syndrome or acute heart failure // Nefrologia. – 2012; 32: 44–52.
  20. Cruz D., Gaiao S., Maisel A. et al. Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review // Clin. Chem. Lab. Med. – 2012; 50: 1533–45.
  21. Lindberg S., Jensen J., Mogelvang R. et al. Plasma neutrophil gelatinase associated lipocalinin in the general population: association with inflammation and prognosis // Arterioscler. Thromb. Vasc. Biol. – 2014; 34 (9): 2135–42.
  22. Daniels L., Barrett-Connor E., Clopton P. et al. Plasma Neutrophil Gelatinase Associated Lipocalin Is Independently Associated With Cardiovascular Disease and Mortality in Community-Dwelling Older Adults // J. Am. Coll. Cardiol. – 2012; 59 (12): 1101–9.
  23. Lindberg S., Pedersen S., Mogelvang R. et al. Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention // JACC. – 2012; 60: 339–45
  24. Bachorzewska-Gajewska H., Tomaszuk-Kazberuk A., Jarocka I. et al. Does neutrophil Gelatinase-Asociated Lipocalin Have Prognostic Value in Patients with Stable Angina Undergoing Elective PCI? A 3-Year Follow-Up Study // Kidney Blood Press Res. – 2013; 37: 280–5.
  25. Lin H., Hwang D., Lee S. et al. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients // Clin. Chem. Lab. Med. – 2015; 53 (1): 73–83.
  26. Zykov M.V., Kashtalap V.V., Zykova D.S. i dr. Prognozirovanie oslozh nenij infarkta miokarda v techenie odnogo goda nabljudenija // Sib. med. zhurn. – 2011; 26 (4–1): 41–6.
  27. Lev E., Kornowski R., Vaknin-Assa H. et al. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention // Am. J. Cardiol. – 2008; 102: 6–11.
  28. Abu-Assi E., Ferreira-Gonzalez I., Ribera A. et al. Do GRACE (Global Registry . of Acute Coronary Events) risk scores still maintain their performance for predicting mortality in the era of contemporary management of acute coronary syndromes? // Am. Heart J. – 2010; 160 (5): 826–34.
  29. Mendez-Eirin E., Flores-Rios X., Garcia-Lopez F. et al. Comparison of the prognostic predictive value of the TIMI, PAMI, CADILLAC, and GRACE risk scores in STEACS undergoing primary or rescue PCI // Rev. Esp. Cardiol. – 2012; 65: 227–33.
  30. Klimkin P.F. Prognozirovanie techenija ostrogo koronarnogo sindro ma v zavisimosti ot urovnja nekotoryh markerov ostrogo povrezhdenija pochek v razlichnyh biologicheskih sredah. Avtoref. dis. … kand. med. nauk. Nizhnij Novgorod, 2014.